文献速递胃肠外科围术期管理与 ERAS

内镜下袖状胃成形术治疗肥胖的早期结果:一项微创手术的3个月疗效与安全性分析

Endoscopic sleeve gastroplasty: early results of a minimally invasive procedure in patients with obesity.
PubMed 文献 · Surg Endosc · 2023-03-15

术后1个月和3个月评估减重效果与安全性:平均%EWL分别为25.4±7.1和36.3±11.4,%TBWL分别为11.2±2.6和15.8±4.2。3个月时仅BMI<40 kg/m2患者出现显著多余体重减少(p=0.001)。ESG安全有效,但显著减重仅见于I级和II级肥胖患者。

要点

  • ESG术后3个月平均%EWL为36.3±11.4,%TBWL为15.8±4.2。
  • 3个月时仅BMI<40 kg/m2患者观察到显著多余体重减少(p=0.001)。
  • 主要不良事件为1例胃壁误缝至腹壁和膈肌,经腹腔镜处理。

核心结论

  • ESG是治疗肥胖安全有效的方法,但3个月时显著减重仅见于I级和II级肥胖患者。

主要发现

  • 平均年龄49.2±9.7岁,女性61例(83.6%),平均初始体重105.7±15.7 kg,平均BMI 38.6±3.5 kg/m2。
  • 中位住院时间2.0±1.8天,62例(84.9%)在24小时后出院。
  • 1例发生胃壁误缝至腹壁和膈肌,经腹腔镜处理。
  • 术后1个月和3个月平均%EWL分别为25.4±7.1和36.3±11.4,%TBWL分别为11.2±2.6和15.8±4.2。
  • 3个月时显著多余体重减少仅见于BMI<40 kg/m2患者(p=0.001)。

临床怎么用

  • ESG可作为I级和II级肥胖患者的微创减重选择,术后3个月可见显著体重下降。
  • 对于BMI≥40 kg/m2患者,ESG术后3个月减重效果不显著,需考虑其他干预策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to analyze the efficacy and safety of endoscopic sleeve gastroplasty at 3 months as well as to determine factors influencing post-procedural weight loss. METHODS: Seventy-three patients with obesity classes I, II and III (BMI 31.1-46.6 kg/m2) underwent ESG between September 2021 and April 2022 at a tertiary care hospital using Overstitch (Apollo Endosurgery, Austin, TX). ESG's efficacy and safety was evaluated at 1 and 3 months post-procedure with regard to excess weight loss (EWL) and total weight loss (TWL). Categorical variables were expressed as percentages and compared with chi-square test while continuous variables were expressed as mean ± standard deviation and compared with paired t test and analysis of variance (ANOVA) as applicable. Pearson's correlation was used to determine association between factors at baseline and weight loss. RESULTS: Mean age was 49.2 ± 9.7 years with 61 (83.6%) patients being female. Mean initial weight was 105.7 ± 15.7 kg, and mean BMI was 38.6 ± 3.5 kg/m2. Median hospitalization was 2.0 ± 1.8 days with 62 (84.9%) patients discharged after 24 h. One patient had accidental suturing of the stomach to the abdominal wall and diaphragm which was managed laparoscopically. Mean %EWL was 25.4 ± 7.1 and 36.3 ± 11.4, and %TBWL was 11.2 ± 2.6 and 15.8 ± 4.2 at 1 and 3 months, respectively. Significant excess weight loss at 3 months was only observed in patients with BMI < 40 kg/m2 (p = 0.001). CONCLUSIONS: ESG is safe and effective to manage obesity. Significant weight loss at 3 months was only observed in patients with obesity class I and class II.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Correia V, Maria B, Paulino A, et al. Endoscopic sleeve gastroplasty: early results of a minimally invasive procedure in patients with obesity. Surg Endosc. 2023. PMID: 36922427. doi:10.1007/s00464-023-09982-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。